Home/Filings/4/0001209191-20-011659
4//SEC Filing

McGuire Jonathan Will 4

Accession 0001209191-20-011659

CIK 0001266806other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:28 PM ET

Size

8.8 KB

Accession

0001209191-20-011659

Insider Transaction Report

Form 4
Period: 2020-02-19
McGuire Jonathan Will
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2020-02-19+5,53225,619 total
  • Sale

    Common Stock

    2020-02-20$5.44/sh1,793$9,75423,826 total
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    2020-02-195,53216,593 total
    Exercise: $0.00From: 2020-02-19Exp: 2023-02-19Common Stock (22,125 underlying)
Footnotes (3)
  • [F1]5,532 shares of common stock acquired upon vesting and release of common stock from restricted stock units (RSUs).
  • [F2]1,793 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs.
  • [F3]The RSUs vest over four years, in equal annual installments, subject to continuous employment.

Issuer

SECOND SIGHT MEDICAL PRODUCTS INC

CIK 0001266806

Entity typeother

Related Parties

1
  • filerCIK 0001345539

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:28 PM ET
Size
8.8 KB